Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification.
Preprints
Blackmer, JE; Jezuit, EA; Chakraborty, A; Montague, RA; Peterson, NG; Outlaw, W; Fox, DT
February 20, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Citation
APA
Chicago
ICMJE
MLA
NLM
Blackmer, J. E., Jezuit, E. A., Chakraborty, A., Montague, R. A., Peterson, N. G., Outlaw, W., & Fox, D. T. (2025). Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. https://doi.org/10.1101/2025.02.19.639165
Blackmer, Jane E., Erin A. Jezuit, Archan Chakraborty, Ruth A. Montague, Nora G. Peterson, William Outlaw, and Donald T. Fox. “Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification.,” February 20, 2025. https://doi.org/10.1101/2025.02.19.639165.
Blackmer JE, Jezuit EA, Chakraborty A, Montague RA, Peterson NG, Outlaw W, et al. Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. 2025.
Blackmer, Jane E., et al. Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. 20 Feb. 2025. Pubmed, doi:10.1101/2025.02.19.639165.
Blackmer JE, Jezuit EA, Chakraborty A, Montague RA, Peterson NG, Outlaw W, Fox DT. Synaptic vesicle glycoprotein 2 enables viable aneuploidy following centrosome amplification. 2025.